 | • レポートコード：D005-00557 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腎臓がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。腎臓がんの種類別市場規模（腎細胞がん（RCC）、移行上皮がん（TCC））、用途別市場規模（外科、免疫療法、化学療法、放射線療法）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Argos Therapeutics、Bristol-Myers Squibb、Novartis、Amgen、AstraZeneca、Bayer、Roche、Pfizer、Aveo Pharmaceuticals、Exelixis、Incyte、Allergan ・地域別グローバル市場分析 2015年-2020年 ・腎臓がんの北米市場（アメリカ、カナダ、メキシコ） ・腎臓がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腎臓がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腎臓がんの南米市場（ブラジル、アルゼンチン） ・腎臓がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腎細胞がん（RCC）、移行上皮がん（TCC） ・用途別分析：外科、免疫療法、化学療法、放射線療法 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Kidney Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Kidney Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Kidney Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Kidney Cancer market has been segmented into:
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
By Application, Kidney Cancer has been segmented into:
Surgery
Immunotherapy
Chemotherapy
Radiation Therapy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Kidney Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Kidney Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Kidney Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Kidney Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Kidney Cancer Market Share Analysis
Kidney Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Kidney Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Kidney Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Kidney Cancer are:
Merck
Argos Therapeutics
Bristol-Myers Squibb
Novartis
Amgen
AstraZeneca
Bayer
Roche
Pfizer
Aveo Pharmaceuticals
Exelixis
Incyte
Allergan
Table of Contents
1 Kidney Cancer Market Overview
1.1 Product Overview and Scope of Kidney Cancer
1.2 Classification of Kidney Cancer by Type
1.2.1 Global Kidney Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Kidney Cancer Revenue Market Share by Type in 2019
1.2.3 Renal Cell Carcinoma (RCC)
1.2.4 Transitional Cell Carcinoma (TCC)
1.3 Global Kidney Cancer Market by Application
1.3.1 Overview: Global Kidney Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Surgery
1.3.3 Immunotherapy
1.3.4 Chemotherapy
1.3.5 Radiation Therapy
1.4 Global Kidney Cancer Market by Regions
1.4.1 Global Kidney Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Kidney Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Kidney Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Kidney Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kidney Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Kidney Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kidney Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Argos Therapeutics
2.2.1 Argos Therapeutics Details
2.2.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Argos Therapeutics SWOT Analysis
2.2.4 Argos Therapeutics Product and Services
2.2.5 Argos Therapeutics Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Amgen SWOT Analysis
2.5.4 Amgen Product and Services
2.5.5 Amgen Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aveo Pharmaceuticals
2.10.1 Aveo Pharmaceuticals Details
2.10.2 Aveo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aveo Pharmaceuticals SWOT Analysis
2.10.4 Aveo Pharmaceuticals Product and Services
2.10.5 Aveo Pharmaceuticals Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.11 Exelixis
2.11.1 Exelixis Details
2.11.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Exelixis SWOT Analysis
2.11.4 Exelixis Product and Services
2.11.5 Exelixis Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.12 Incyte
2.12.1 Incyte Details
2.12.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Incyte SWOT Analysis
2.12.4 Incyte Product and Services
2.12.5 Incyte Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Allergan SWOT Analysis
2.13.4 Allergan Product and Services
2.13.5 Allergan Kidney Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Kidney Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Kidney Cancer Players Market Share
3.2.2 Top 10 Kidney Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Kidney Cancer Revenue and Market Share by Regions
4.2 North America Kidney Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Kidney Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Kidney Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Kidney Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Kidney Cancer Revenue and Growth Rate (2015-2020)
5 North America Kidney Cancer Revenue by Countries
5.1 North America Kidney Cancer Revenue by Countries (2015-2020)
5.2 USA Kidney Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Kidney Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Kidney Cancer Revenue and Growth Rate (2015-2020)
6 Europe Kidney Cancer Revenue by Countries
6.1 Europe Kidney Cancer Revenue by Countries (2015-2020)
6.2 Germany Kidney Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Kidney Cancer Revenue and Growth Rate (2015-2020)
6.4 France Kidney Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Kidney Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Kidney Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Kidney Cancer Revenue by Countries
7.1 Asia-Pacific Kidney Cancer Revenue by Countries (2015-2020)
7.2 China Kidney Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Kidney Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Kidney Cancer Revenue and Growth Rate (2015-2020)
7.5 India Kidney Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Kidney Cancer Revenue and Growth Rate (2015-2020)
8 South America Kidney Cancer Revenue by Countries
8.1 South America Kidney Cancer Revenue by Countries (2015-2020)
8.2 Brazil Kidney Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Kidney Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Kidney Cancer by Countries
9.1 Middle East & Africa Kidney Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Kidney Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Kidney Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Kidney Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Kidney Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Kidney Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Kidney Cancer Market Forecast by Type (2019-2024)
10.3 Renal Cell Carcinoma (RCC) Revenue Growth Rate (2015-2025)
10.4 Transitional Cell Carcinoma (TCC) Revenue Growth Rate (2015-2025)
11 Global Kidney Cancer Market Segment by Application
11.1 Global Kidney Cancer Revenue Market Share by Application (2015-2020)
11.2 Kidney Cancer Market Forecast by Application (2019-2024)
11.3 Surgery Revenue Growth (2015-2020)
11.4 Immunotherapy Revenue Growth (2015-2020)
11.5 Chemotherapy Revenue Growth (2015-2020)
11.6 Radiation Therapy Revenue Growth (2015-2020)
12 Global Kidney Cancer Market Size Forecast (2021-2025)
12.1 Global Kidney Cancer Market Size Forecast (2021-2025)
12.2 Global Kidney Cancer Market Forecast by Regions (2021-2025)
12.3 North America Kidney Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Kidney Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Kidney Cancer Revenue Market Forecast (2021-2025)
12.6 South America Kidney Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Kidney Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Kidney Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Kidney Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Kidney Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Kidney Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Kidney Cancer Major Business
Table 7. Merck Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Kidney Cancer Product and Solutions
Table 10. Merck Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Argos Therapeutics Corporate Information, Location and Competitors
Table 12. Argos Therapeutics Kidney Cancer Major Business
Table 13. Argos Therapeutics Kidney Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Argos Therapeutics SWOT Analysis
Table 15. Argos Therapeutics Kidney Cancer Product and Solutions
Table 16. Argos Therapeutics Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Kidney Cancer Major Business
Table 19. Bristol-Myers Squibb Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb SWOT Analysis
Table 21. Bristol-Myers Squibb Kidney Cancer Product and Solutions
Table 22. Bristol-Myers Squibb Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Kidney Cancer Major Business
Table 25. Novartis Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Kidney Cancer Product and Solutions
Table 28. Novartis Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Amgen Corporate Information, Location and Competitors
Table 30. Amgen Kidney Cancer Major Business
Table 31. Amgen Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Amgen SWOT Analysis
Table 33. Amgen Kidney Cancer Product and Solutions
Table 34. Amgen Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Kidney Cancer Major Business
Table 37. AstraZeneca Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Kidney Cancer Product and Solutions
Table 40. AstraZeneca Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Corporate Information, Location and Competitors
Table 42. Bayer Kidney Cancer Major Business
Table 43. Bayer Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Bayer SWOT Analysis
Table 45. Bayer Kidney Cancer Product and Solutions
Table 46. Bayer Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Roche Corporate Information, Location and Competitors
Table 48. Roche Kidney Cancer Major Business
Table 49. Roche Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Roche SWOT Analysis
Table 51. Roche Kidney Cancer Product and Solutions
Table 52. Roche Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Kidney Cancer Major Business
Table 55. Pfizer Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Kidney Cancer Product and Solutions
Table 58. Pfizer Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Aveo Pharmaceuticals Corporate Information, Location and Competitors
Table 60. Aveo Pharmaceuticals Kidney Cancer Major Business
Table 61. Aveo Pharmaceuticals Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 62. Aveo Pharmaceuticals SWOT Analysis
Table 63. Aveo Pharmaceuticals Kidney Cancer Product and Solutions
Table 64. Aveo Pharmaceuticals Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Exelixis Corporate Information, Location and Competitors
Table 66. Exelixis Kidney Cancer Major Business
Table 67. Exelixis Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 68. Exelixis SWOT Analysis
Table 69. Exelixis Kidney Cancer Product and Solutions
Table 70. Exelixis Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Incyte Corporate Information, Location and Competitors
Table 72. Incyte Kidney Cancer Major Business
Table 73. Incyte Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 74. Incyte SWOT Analysis
Table 75. Incyte Kidney Cancer Product and Solutions
Table 76. Incyte Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Allergan Corporate Information, Location and Competitors
Table 78. Allergan Kidney Cancer Major Business
Table 79. Allergan Kidney Cancer Total Revenue (USD Million) (2017-2018)
Table 80. Allergan SWOT Analysis
Table 81. Allergan Kidney Cancer Product and Solutions
Table 82. Allergan Kidney Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Kidney Cancer Revenue (Million USD) by Players (2015-2020)
Table 84. Global Kidney Cancer Revenue Share by Players (2015-2020)
Table 85. Global Kidney Cancer Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Kidney Cancer Revenue Market Share by Regions (2015-2020)
Table 87. North America Kidney Cancer Revenue by Countries (2015-2020)
Table 88. North America Kidney Cancer Revenue Market Share by Countries (2015-2020)
Table 89. Europe Kidney Cancer Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Kidney Cancer Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Kidney Cancer Revenue by Countries (2015-2020)
Table 92. South America Kidney Cancer Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Kidney Cancer Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Kidney Cancer Revenue Market Share by Countries (2015-2020)
Table 95. Global Kidney Cancer Revenue (Million USD) by Type (2015-2020)
Table 96. Global Kidney Cancer Revenue Share by Type (2015-2020)
Table 97. Global Kidney Cancer Revenue Forecast by Type (2021-2025)
Table 98. Global Kidney Cancer Revenue by Application (2015-2020)
Table 99. Global Kidney Cancer Revenue Share by Application (2015-2020)
Table 100. Global Kidney Cancer Revenue Forecast by Application (2021-2025)
Table 101. Global Kidney Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Kidney Cancer Picture
Figure 2. Global Kidney Cancer Revenue Market Share by Type in 2019
Figure 3. Renal Cell Carcinoma (RCC) Picture
Figure 4. Transitional Cell Carcinoma (TCC) Picture
Figure 5. Kidney Cancer Revenue Market Share by Application in 2019
Figure 6. Surgery Picture
Figure 7. Immunotherapy Picture
Figure 8. Chemotherapy Picture
Figure 9. Radiation Therapy Picture
Figure 10. Global Kidney Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Kidney Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Kidney Cancer Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Kidney Cancer Revenue Market Share in 2019
Figure 19. Global Top 10 Players Kidney Cancer Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Kidney Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Kidney Cancer Revenue Market Share by Regions (2015-2020)
Figure 23. Global Kidney Cancer Revenue Market Share by Regions in 2018
Figure 24. North America Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 25. Europe Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 27. South America Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 29. North America Kidney Cancer Revenue Market Share by Countries (2015-2020)
Figure 30. North America Kidney Cancer Revenue Market Share by Countries in 2019
Figure 31. USA Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 32. Canada Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Europe Kidney Cancer Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Kidney Cancer Revenue Market Share by Countries in 2019
Figure 36. Germany Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 37. UK Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 38. France Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 39. Russia Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 40. Italy Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Kidney Cancer Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Kidney Cancer Revenue Market Share by Countries in 2019
Figure 43. China Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 44. Japan Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Korea Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 46. India Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 48. South America Kidney Cancer Revenue Market Share by Countries (2015-2020)
Figure 49. South America Kidney Cancer Revenue Market Share by Countries in 2019
Figure 50. Brazil Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Kidney Cancer Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Kidney Cancer Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 55. UAE Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Kidney Cancer Revenue and Growth Rate (2015-2020)
Figure 58. Global Kidney Cancer Revenue Share by Type (2015-2020)
Figure 59. Global Kidney Cancer Revenue Share by Type in 2019
Figure 60. Global Kidney Cancer Market Share Forecast by Type (2021-2025)
Figure 61. Global Renal Cell Carcinoma (RCC) Revenue Growth Rate (2015-2020)
Figure 62. Global Transitional Cell Carcinoma (TCC) Revenue Growth Rate (2015-2020)
Figure 63. Global Kidney Cancer Revenue Share by Application (2015-2020)
Figure 64. Global Kidney Cancer Revenue Share by Application in 2019
Figure 65. Global Kidney Cancer Market Share Forecast by Application (2021-2025)
Figure 66. Global Surgery Revenue Growth Rate (2015-2020)
Figure 67. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 69. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 70. Global Kidney Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Kidney Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Kidney Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Kidney Cancer Revenue Market Forecast (2021-2025)
Figure 74. Europe Kidney Cancer Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Kidney Cancer Revenue Market Forecast (2021-2025)
Figure 76. South America Kidney Cancer Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Kidney Cancer Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
腎臓がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Kidney Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 4731.4 million by 2025, from USD 4023.6 million in 2019. The Kidney Cancer Dr…- 腎線維症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Kidney Fibrosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidney Fibrosis Tre…
- 腎臓/腎機能検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Kidney/Renal Function Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidney/Renal Funct…
- 移行上皮がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Transitional Cell Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transit…
- 腎臓デトックスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Kidney Detox market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidney Detox market report provi…